We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
-$9.81M
Cap. Flow
-$12.1M
Cap. Flow %
-10.37%
Top 10 Hldgs %
48.94%
Holding
61
New
9
Increased
18
Reduced
15
Closed
17

Top Buys

1
JD icon
JD.com
JD
+$4.9M
2
AWI icon
Armstrong World Industries
AWI
+$1.98M
3
KKR icon
KKR & Co
KKR
+$1.89M
4
KALA icon
KALA BIO
KALA
+$1.87M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.87M

Top Sells

1
ZGNX
Zogenix, Inc.
ZGNX
+$3.74M
2
RXDX
Ignyta, Inc.
RXDX
+$2.11M
3
WBC
WABCO HOLDINGS INC.
WBC
+$1.74M
4
ESPR
Esperion Therapeutics
ESPR
+$1.7M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$1.7M

Sector Composition

1 Healthcare 44.68%
2 Financials 35.04%
3 Consumer Discretionary 4.42%
4 Industrials 3.63%
5 Technology 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.06T
$34.8M 29.88%
117
– –
JD icon
2
JD.com
JD
$40B
$5.15M 4.42%
+124,440
New +$4.9M
TFCF
3
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$2.22M 1.9%
65,055
+5,804
+10% +$170K
WVE icon
4
Wave Life Sciences
WVE
$1.12B
$2.21M 1.9%
63,013
-33,209
-35% -$968K
AWI icon
5
Armstrong World Industries
AWI
$6.66B
$2.18M 1.87%
+35,959
New +$1.98M
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
$2.15M 1.85%
62,926
+9,487
+18% +$302K
ONC
7
BeOne Medicines Ltd
ONC
$32.4B
$2.15M 1.84%
21,956
-1,105
-5% -$101K
TRN icon
8
Trinity Industries
TRN
$2.9B
$2.06M 1.77%
76,264
-3,452
-4% -$86.1K
BFH icon
9
Bread Financial
BFH
$4.01B
$2.05M 1.76%
10,156
+886
+10% +$164K
AVXS
10
DELISTED
AveXis, Inc. Common Stock
AVXS
$2.04M 1.75%
18,474
+607
+3% +$60.9K
ACAD icon
11
Acadia Pharmaceuticals
ACAD
$4.38B
$2.04M 1.75%
67,758
+14,781
+28% +$473K
ASND icon
12
Ascendis Pharma A/S
ASND
$17.1B
$2.04M 1.75%
50,813
-9,063
-15% -$330K
DBVT
13
DBV Technologies
DBVT
$870M
$2.02M 1.73%
8,192
+4,354
+113% +$1.26M
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.01M 1.72%
74,378
+16,440
+28% +$453K
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
$2.01M 1.72%
16,773
+4,490
+37% +$547K
NGNE icon
16
Neurogene
NGNE
$744M
$2M 1.72%
8,520
+2,357
+38% +$552K
MS icon
17
Morgan Stanley
MS
$339B
$1.99M 1.71%
37,911
+2,094
+6% +$106K
KKR icon
18
KKR & Co
KKR
$90.6B
$1.98M 1.7%
+93,944
New +$1.89M
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.97M 1.69%
22,137
+2,354
+12% +$205K
STX icon
20
Seagate
STX
$178B
$1.97M 1.69%
47,154
-3,396
-7% -$130K
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
$1.96M 1.68%
48,843
-97,414
-67% -$3.74M
FOLD
22
DELISTED
Amicus Therapeutics
FOLD
$1.95M 1.67%
135,364
+2,885
+2% +$39.6K
MSFT icon
23
Microsoft
MSFT
$2.93T
$1.94M 1.66%
22,655
-123
-0.5% -$10.1K
NBIX icon
24
Neurocrine Biosciences
NBIX
$17.2B
$1.94M 1.66%
24,945
-5,537
-18% -$378K
BCRX icon
25
BioCryst Pharmaceuticals
BCRX
$2.36B
$1.88M 1.62%
383,768
+23,726
+7% +$115K
1
2 3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q4 2017 Portfolio in Review

As of Q4 2017, Emory University held 61 positions worth $117M, down 7.8% from $126M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Emory University withdrew a net $12.1M in Q4 2017, closing 17 positions and reducing 15 holdings. Its most notable exit was Ignyta, Inc., an estimated $2.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Emory University opened a new position in JD.com worth $5.15M.

  • Emory University's largest Q4 2017 buy was JD.com: 124,440 shares worth $5.15M.
  • Emory University added most to DBV Technologies in Q4 2017, an estimated $1.26M increase.
  • Emory University's biggest Q4 2017 reduction was Zogenix, Inc., cutting an estimated $3.74M.
  • Emory University fully exited Ignyta, Inc. in Q4 2017, selling an estimated $2.11M.
  • Emory University's ten largest holdings make up 49% of its $117M portfolio in Q4 2017.
  • Emory University opened 9 new positions and closed 17 in Q4 2017.
  • Emory University's portfolio value fell 7.8% quarter-over-quarter to $117M.

Based on Emory University's 13F filing for Q4 2017, filed 13 Feb 2018.